Member Info for JustHereForHemo

His tweet is referring to: https://biodefensecommission.org/events/banding-together-partnerships-for-biodefense/
The photo he provided is not a front on capture and a quick reverse look up shows no results so either he took the photo personally or was provided the photo. I would guess that he attended to watch/listen/network but who knows.
If you watch that video there are multiple companies almost "pitching" themselves and what they have to offer, from treatments to bio devices for diagnosis in the home. These are the people that can open doors to funding and if this is the circle that Vlad is walking and talking then we have every reason to be optimistic.

Speaker list:
• The Honorable Rajesh Panjabi – Special Assistant to the President and Senior Director for Global Health Security & Biodefense, National Security Council, The White House
• Dr. Anthony Fauci – Chief Medical Advisor to President Biden; Director of the National Institute of Allergy and Infectious Diseases, National Institutes of Health
• Representative David Trone (D-MD)
• Dr. Sandeep Patel – Director of BARDA’s Division of Research, Innovation, and Ventures
• Labeeb Abboud – Chairman and CEO, Global Health Investment Corporation
• The Honorable Ali Nouri – Assistant Secretary for Congressional and Intergovernmental Affairs, Department of Energy
• Dr. Gilda Barabino– President, of American Association for the Advancement of Science
• Stu Solomon – President & CEO of Connected DMV
• Dr. Maria Croyle – Jurata Thin Film
• Brian Wiley – ENA Respiratory
• Dr. Bruce Batten – GRIP Molecular

disagree

Apologies, didnt see you had already posted, looks promising :-) Obviously have to caveat by saying there is no guarantee Hemo will get anything, but it looks like they can!

I just.... Dont.... What... I dont know where to start... "CBR clearly a failure, no update after this long means its been shelved like everything else."... I really want to put in that "Not sure if trolling or serious" Gif....

Update on CBR 2 months ago: https://youtu.be/LFH95Zw8e6Y Sounded extremely positive so unless you have some inside source I am calling BS.
In fact Vlad just posted this:
"New York State Biodefense Commercialization Fund - quite exciting and very timely!
https://esd.ny.gov/biodefensefund"
"the Fund offers grants to startups ... that are developing promising diagnostics, vaccines, therapeutics, ... that address or mitigate infectious disease threats." - Pretty good description of CBR if you ask me....
"Startup and early stage companies based in New York"

Obviously no guarantee that Hemo will apply or that even if they do it will be granted but I read though the T&C and it SOUNDS like Hemo are eligible and can apply for a grant of £1-4mil.
Vlad did say they were looking at non dilutive funding, grants like this IF they get would be huge considering the mCap is only £14m.

Vlad gets abuse for lack of news updates, which frankly is misplaced.
Take one example CBR update start of the year. Arguably best RNS update from Hemo I have ever read and was better than I could ever have hoped for.
That has not changed.
But for 90% of the readers on here they base the quality of the RNS on how the market reacts. The SP fell so clearly it was a bad update for some reason and quickly forgotten and Vlad back on the hook for no updates.
Is that fair? No. But that is what happens. People here base their opinion of Hemogenyx on how the SP performs after an update which is why I lose my temper so often for many who completely fail to read updates and assign value independently of the market reaction.

You are right, Vlad does do alot of conferences, but not being able to see them I question why that never translates into any follow up? Why for the past year have I never seen any sort of excitement or PR outside the paid for channels?
I honestly dont get it and I dont have an answer, but I do know that I see lots of chat and posts in my news feeds from other small pharma about exciting developments often much less significant than CBR. But Hemo is a black hole.

And yes, there are alot of CEOs much less active than Vlad, but go and check the company websites, I am sure (certainly for oil&gas and mining stocks) there is timetables and clear updates on progress, media releases that dont require an RNS. There are plenty of small cap pharma also that release no updates, but by and large they are not public so have no shareholders to update.

Anyway, this is not me attacking Vlad, I am just frustrated that there are so few people even aware of the work being done and failing to see the potential. Vlad is a good man who wants to prove his science works and save lives and hopes that the market will reward him for that. But this is business, he did that 2 years ago and just trusted the markets would reward him when he took out the CLNs and we know how that turned out....

"How can one possibly demand more than what they have already achieved?" - The problem is how many people know what they have already achieved? The conferences have not delivered as much as we appreciate him doing them.
There is alot that Vlad could change to improve his image and with it the share price, but he is unlikely to do so, change does not mean extra work, it just means change. But he is a brilliant scientist who is too busy right now I am sure so realistically I expect nothing more. I am confident this company will deliver and soon and the haters will be proven wrong, but I hate that Vlad is missing so many opportunities now to improve his image and help investors.

I agree with HT, whilst I have no idea how significant such news would be, the expectation was that there would be progress in CDX. Perhaps not warranting an RNS but if thats the case and it was important enough to highlight to investors before then its important enough to inform investors its done, even if that is informal and not via RNS/REACH.
Also agree about CBR, arguably one of the biggest developments in immunology and its gone dark, perhaps this is a good thing and talks are ongoing but we don't know this.

Create a vacuum and it will be filled. It can be filled by Vlad and Hemogenyx with status updates or at least confirmatory statements that things are ongoing, or it will be filled by trolls.

For the record I disagree about the lack of updates for CAR-T, IMO updates here have been excellent, Good clear explanation of the process in the zoom call and lots of good clear steps via twitter and RNS.

I guess for many of the frustrated investors here HK the issue is not so much lack of news but lack of exposure, take Valirx, its up what? 20% today? Dr Suzy Dilly is loved by many of her investors because she shows empathy for investors. They have made mistakes sure, but comes across as making an effort to represent investors to the greater public, think she made a statement about progress but didnt have to be an RNS and market rewards it.

There is a line, some CEOs literally take investors for a ride, they pump their stock regularly to get away placings, immoral and wrong and I am glad Vlad is not like this. But then with Hemogenyx its the reverse, its incoherent, mostly silence like I said creating a vacuum and occasional spurts of publicity that just never last, like Vlad is the only one capable of engaging and when he is ultra busy and the company is clearly at a very exciting cross roads he is too busy and the PR and engagement shuts down, but then when you have a few weeks like earlier this year when Vlad did the meetings there was tonnes of information provided.

The meetings, the twitter, they are FANTASTIC for people like myself who love to know whats going on, but the audience is so small. Interviews with Zak and David, again small audiences who only want ST trades. Google Hemogenyx and you find nothing, nobody outside this small community talks about Hemo and only ever spend their time demanding "big news". Nobody seems to attach any value to achievements to date.

I am frustrated, I see a £14m company sitting on IP worth IMO billions few months from clinical trials which should be worth 10 times that. I see nothing but negative comments and the CEO, who is a brilliant scientist is blinkered in the role of CSO to the detriment of all else. A video of someone moping is nice. Public statements are better.

Such loyal and supportive investors who are able to stand back, see the value of what has already been achieved and the potential of what is to come. I am sure Vlad is overwhelmed with the support :-)
Have a great weekend everyone!

Oh sweet Jesus.... MrIndia.... Its not a "mock up" or a fake.... Like on what planet would Vlad fake such a simple video just showing a bit of staff training?..... Please, switch off and go take up pottery or bee keeping.

The future is bright, the future is Hemo :-)
ZaphodBe... ZB, I honestly dont believe its a lack of news or progress is the issue its just a complete and utter lack of visibility. I am sure when Vlad goes to these conferences he does so with the best of intentions but its not translating into exposure in the larger market.
MrIndia and others can stamp their feet about lack of updates and progress, I would like more also, but when you look back over the last few years there HAS been alot of progress and updates.
It just seems to get completely overlooked by the market as a whole as its only ever the same investors (well mostly traders) who make any noise about it. Go and google Hemogenyx, it never appears anywhere except for RNS reprints, ZERO discussion.

I am hoping that Vlad goes to teh conference next week and grabs the audience by the balls and makes it clear in no uncertain terms:
Hemogenyx ARE going clinical
They HAVE spoken to the FDA and are in the final stages of IND
They HAVE tested CAR-T in collaboration with Penn and others
Hemogenyx are Massively undervalued but fully funded into trials
He believes 100% that Hemogenyx will be a "life saving company PDQ"
CBR has the potential to be a paradigm shift in treatment for both current and future diseases.

Hemogenyx is not the only ones presenting and certainly not the biggest, but this close to a fundamental shift Vlad hopefully will be one of the loudest.

I am optimistic we are further ahead than most people think but without confirmation from the man himself its speculation. It looks like vlad has gone silent on twitter so maybe these steps are deemed too sensitive for informal twitter updates? Either way I expect it to be made clear what stage they are on when they release the results in a few weeks time, along side updates for CBR and CDX.

Haywain he already stated a full production run on its own takes ~ 1 month that includes the 12 days, and that includes sending away the sample for testing etc. Why would he pay to send this pilot run away for official testing if its not one of the 3 manufacturing runs? Dont forget they have done one of these runs already earlier in the year off site, they know the process works, they know the CAR-T is suitable for taking to trials, this is just about doing the same steps alone, in house on their own equipment, can think of no reason why that would take an extra month... I would say there is every chance they have already started or are preparing to start the first manufacturing runs based on the twitter timelines. But until Vlad confirms one way or the other we dont know for sure.
As for running in parallel, I agree its unlikely, vlad probably thinks the CLNs were a good idea.... so no, I dont expect them to expedite the 3 runs, but its possible, the recent appointments may push Vlad to think more logically about the business side of things. To justify this:

Staff costs YE 2021 £1.023m - This year they have increased headcount. Total Administrative Expenses was £2.57m. Its safe to assume this figure will be higher this year. *NOTE* They have plenty of money dont be getting knickers in a twist. However lets round up and say expenses up to £3m per year or £250k per month just in overheads.
If the bottleneck in these production runs is A, 12 days in cocoon before the sample is sent for testing then that means at most in parallel they could do maybe 2 runs. So does a new cocoon device cost more than £125k? If the answer is no and staff are not otherwise utilised at 100% then the smart move is to buy more devices. MAYBE they have, I dont know.

This is not just my maths btw, here is a case study from elsewhere:
Clean room with one machine for closed and automated manufacturing installed, annual fixed costs summed up to approximately €438?098 ($584?131).
The variable cost per production was roughly €34?798 ($46?397).
At the maximum capacity of one machine, total cost per product would be close to €60?000 ($78?849).
If three machines were to be installed in the clean room, per production cost could be as low as €45?000 (roughly $59905).

Economies of scale, simple economics. But again, maybe they can justify taking months and months doing things in series and waiting.....

07-Sep-22 -08:10:38 - 1.4715*340,000 = 5,003
At that time CINE was ~4.8p to buy now about 4.1 to sell so your about 15% down on your trade (Although every chance of a gap down in the morning.. The US listing is CNNWF and its 8% down. IF you manage to sell at 4.1 and decide to come back the buy price is 1.4825, so with your 4300 you could buy back 290,050 (excluding any fees) for a loss of 50k shares (provided you can buy at 1.4825 and you can sell at 4.1p, neither of which is certain.

All that said, it could have been much better news, or perhaps my understanding of chapter 11 is flawed? Perhaps this trade will work out for you and I hope it does. My point is there is every likelihood your trade has hurt your pocket and your constant trading certainly does nothing to help this share as a whole.

It has given me more confidence in my decision to just wait here. It may be boring, it may be a dead share in terms of volume. But they are fully funded, news is coming at some point and its reasonably low risk (IND application requires 3 repeated runs of manufacturing, thats time/labour intensive but not risky). Money to be made playing the market these days with all the swings, but also money to be lost, I am sticking with Hemo. I am not saying "News tomorrow" but that certainly is possible and I for sure dont want to take the risk I am out when the next updates do land.

You sold here at an extremely low price with pending updates on CBR and CDX with a very clear timeline for CAR-T and instead bought into CINE which at that time was what? 20% spiked up? And has filed a chapter 11????
You do understand that Chapter 11 filing is not good news for shareholders right?..... I wish you the best of luck at CINE but I certainly wont be following you.

I know two people with inside information:
Mr Stuart Tinch, recently appointed as Director of Quality:
"I have been privileged to join Hemogenyx Pharmaceuticals to establish its quality system. It is great to be able to facilitate the transition of brilliant science into the clinic for the benefit of patients."

Dr Koen van Besien as Medical Director:
"I have been privileged to work with Hemogenyx since its founding. It is great to see their research efforts come to fruition and I am committed to helping bring their first product to the clinic."

As much as everyone is entitled to their own opinion of Hemo and Vlad these two are experts, they have delivered clinical products to commercial success. They are getting involved right now along side the delivery from WuXi and the sign off of the new lab facilities.
Its right there in the webinair, 3 manufacturing runs to complete IND application.
Vlad has been on twitter demonstrating the pre-run which is either now complete or very near (~12 days, video was 22/09 but we really dont know how long was remaining at that point).

Vlad also said a single full complete manufacturing run would take ~1month including all tests and report generation etc.
Worst case scenario thats 3 runs back to back.
Mid case scenario they run staggered in parallel to maximise use of limited equipment.
Best case scenario they have sufficient equipment to run multiple runs in full parallel.

So WORST case scenario IMO is November/December for completion and IND application
BEST case scenario I am not even going to say but I really dont think these new appointments would have jumped onboard in a more active capacity right now if they thought IND was 4 months away?

I am struggling to understand the lack of enthusiasm, but such is life, I speak to MrIndia frequently and he is extremely confident about Hemo whilst being extremely depressing all because of the share price. I get it, its pants, but seriously, why so little excitement? There are posters on here with millions of shares, you clearly believe in the company, every sign now is that Hemo will be a clinical Pharma very likely by end of the year (IND, I am NOT saying they will have injected anyone yet as IDK how hard it is to find patients). YES the SP is rubbish, does that have any impact whatsoever on the potential? Does it make CAR-T any less likely to go IND very soon? Does it make it any less likely to save lives?
This is a wholly owned Oncology CAR-T candidate. These get licenced/bought for 100s of millions when proven. Companies with clinical CAR-T candidates in trials are NOT 14mil mCap companies. How much clearer does it need to be that a serious re-rate IS going to happen and in pretty short order. Could take weeks or months fair enough, but for dam sure you wont see that sort of return in premium bonds unless ERNIE smiles on you!

Anyway, as you can tell I also am extremely confident, have a great weekend all :-)

Do you need inside information to say that?
The CEO laid out clearly in a recorded webinair the steps required before IND, the final piece being the 3 engineering runs.
That same CEO then progresses to provide multiple updates via twitter with videos showing progress though to the engineering runs. We know what they are doing, we know they have the money and now several staff members who have done this time and again. It may be new to Vlad but he has experts at his side to whom IND applications and going clinical is old hat.
Not sure how much clearer it could be that things are going well...

Honestly no idea why you have jumped to that conclusion? Just because SP is up 5%? That might be significant for a company like BP or Vodafone but not small caps like this where a few thousand pounds can move the SP 5% and not an indicator of RNS being lodged...
HFH posted a few items that are surely due soon so pumpkin IMO your timing was excellentr. Just to repeat what has been said with regards to pending positive updates:
Vlad DID say the website was being worked on, at some point it will land, use tea leaves to predict when.
CDX - Master Cell bank establishment predicted July/August 2022 then GLP Toxicity Report 2H22/1H23.
CBR - With a third party for validation in vitro/in vivo - This begun early this year after patent protection so really update could come any time. I expect it to be validation that CBR works and some sort of agreement signed to take it forward, but its possible that CBR does not work or third party not taking it forward.

CAR-T This one is the most transparent, no guessing or jumping to conclusions required. Vlad has been completely open with the process explaining exactly what they are doing here:
https://youtu.be/LFH95Zw8e6Y
To understand where that fits with the current timeline, you need to follow the Hemogenyx twitter feed:
https://twitter.com/HemogenyxPharma/status/1561797921749798913
22nd August "T cells are loaded into the Cocoon for preliminary expansion"
If you watch the YouTube you will see the description of the steps to IND. 1 Run with expansion in Cocoon takes 12 days so probably next week they will know if this Model Hemo-CAR-T Manufacturing run was successful allowing them to kick off the first Engineering Manufacturing Run. Will this progress be RNS'ed? IMO no but I expect it to be on twitter like every other step showing progress which is more than enough.
This mCap/SP is not sustainable as this tiny minnow gets closer and closer to clinical.
Vlad has brought on board some of the leading names in their fields and has established an office and laboratory facility with the capacity to take Hemo commercial whilst reducing external dependencies.

Nice to see us blue but a very long way to go before getting excited, we need to do 1000% just to hit previous ATH SP and something like 400% just to hit previous ATH mCap. But I am very confident that will happen as news starts to flow :-)

https://www.aquis.eu/aquis-stock-exchange/rules-and-regulations/market-notices/aqse-disciplinary-notice-0

For the reasons given in this notice, Aquis Stock Exchange (“AQSE” or “the Exchange”) has censured and imposed a financial penalty on Love Hemp in the sum of £100,000, which has been discount to £70,000 for early settlement.

Looks like this is why its been suspended for so long, hopefully now will be able to appoint new adviser and start trading again. IMO the suspension and action by AQUIS has hopefully forced some much needed changes internally and this is positive for share holders. Time will tell if lessons have been learned, good luck to existing share holders, lets see what the coming days and weeks bring!

The videos show significant progress and did appease and satisfy many LTH'ers(yourself excluded clearly) who are now more confident and reassured that CAR-T is on track and looking good. They were not RNS'ed because Vlad does not need to RNS every single step. As such the audience was limited to existing followers. Whilst the videos show progress its still a long process, the IND wont be in the next month or two (I believe) so hardly going to cause an immediate rush to buy.

You and everyone else here knows at some point this will be worth many multiples. The problem for you is timescales, you cannot afford to wait, but instead of doing anything productive you keep engaging in self destructive trolling on here instead of either shutting up and let people post positively OR trying to maybe spread some positive updates yourself, twitter is after all a free platform. There are people on the sidelines planning to buy before IND, updates like yesterday are bound to cause a bit of itchy bum syndrome, it is a game of chicken and there ARE traders/ex-LTH'ers who are out and plan to be in before this moves. How much longer do people really expect them to wait?
The information feed from hemo has been increasing with progress on production and staffing so it feels like things are really ramping up to climax and JUST for CAR-T for once it feels like the company is on track with projections found:
Per https://youtu.be/LFH95Zw8e6Y
Manufacturing Run Aug/Sept - Per twitter happening now, if successful they will start the 3 Engineering runs. After that... IND. But here is the catch, we (myself included) jumped to conclusions and assumed each run would be a consecutive 1 month period starting in September finishing in December. Maybe correct, maybe not, who knows.
IF the Cocoon is the limiting factor taking 12 days to expand the cells then allowing a day either side and overlapping testing for one batch whilst the next is in the Cocoon means 4 runs would take 10 weeks.
Or maybe they will do a full run, manufacture and test before even starting the next run and it will be 3 full months? That is a pretty big window.

The itchy bum squad think they have time, and maybe they do.... Perhaps there will be no surprise update on CBR with a partner or no update on CDX... Perhaps each run of CAR-T will take a month and the rest of the sideliners will be just as ballsy and wait to the last minute. But they are not competing against the bored SH'ers sitting waiting, they are competing against themselves. Who will blink first... Everyone of them who decides they have waited long enough will end up pushing up the price for the rest... Tick Tock.......

Basically when this share is blue you are bubbly optimistic, happy, ready to buy more shares. When its red or even flat with a few sells your on here posting BS, doom and gloom, end of the world, vlad is the cause of all lifes woes.....
Yet its often off the back of < 500k sells, a tiny volume day, seriously its really frustrating and I am biting my tongue... Is it an absolute bargain? Yes. Would I pump in £500k if I had it sitting around? Yes. Is it crazy and mad that people still chose to sell? Yes.
Do we want to hear you going on and on about it? No. S417 happens, people trade, people sell. If you cannot get past the fact that this is a share on the open market that people are going to trade irrespective of how well the company is actually doing where it matters in the lab with the science then you really need to sell up and invest in something else.

MrIndia, if people are unable to look at https://www.lse.co.uk/rns/HEMO/ and deduce the following:
They have a candidate which they have spoken to the FDA about in PIND who have told Hemo exactly what is required as part of IND
They have pre-clinicalresults that prove it is effective in tests
They have the funds required for clinical trials
They have a brand spanking new clean room and lab either certified or soon to be signed off
They have some of the worlds leading scientists either activly involved in preparing for clinical trials or advising
They have highly qualified leaders overseeing the production of CAR-T for clinical trials
They have an agreement with Penn a class leader in CAR-T signed up to run the first trials.

And Vlad has laid out the steps required and the target market he is aiming for.

Sorry but for CAR-T what exactly else do people want? Its all there in black and white, if people dont want to invest or want to sell, let them and stop obsessing with what others are doing. Either you believe the regulated RNS's and updates or you dont in which case you should not be here. We were told the estimated timelines in the recent presentation and pretty much everything is still within that timeline, We have had the odd tweet or video clip showing progress so clearly not every single little step require an RNS. These "Holding updates" are not for your benefit or anyone elses, Vlad is extremely tight and I am pretty sure if he didnt have to pay for an RNS to announce key positions he would not.

Deciding how well a company is doing or arriving at some convoluted conclusion that thing are delayed or going badly because people are not buying is just stupid and the reason so many wipe themselves out because they turn into sheep following what others are doing and always a step behind.